Discovering robust biomarkers of neurological disorders from functional MRI using graph neural networks: A Review

Yi Hao Chan,Deepank Girish,Sukrit Gupta,Jing Xia,Chockalingam Kasi,Yinan He,Conghao Wang,Jagath C. Rajapakse
2024-05-01
Abstract:Graph neural networks (GNN) have emerged as a popular tool for modelling functional magnetic resonance imaging (fMRI) datasets. Many recent studies have reported significant improvements in disorder classification performance via more sophisticated GNN designs and highlighted salient features that could be potential biomarkers of the disorder. In this review, we provide an overview of how GNN and model explainability techniques have been applied on fMRI datasets for disorder prediction tasks, with a particular emphasis on the robustness of biomarkers produced for neurodegenerative diseases and neuropsychiatric disorders. We found that while most studies have performant models, salient features highlighted in these studies vary greatly across studies on the same disorder and little has been done to evaluate their robustness. To address these issues, we suggest establishing new standards that are based on objective evaluation metrics to determine the robustness of these potential biomarkers. We further highlight gaps in the existing literature and put together a prediction-attribution-evaluation framework that could set the foundations for future research on improving the robustness of potential biomarkers discovered via GNNs.
Machine Learning,Signal Processing,Neurons and Cognition
What problem does this paper attempt to address?
This paper aims to solve the problem of using graph neural networks (GNNs) to discover robust biomarkers for neurological diseases from functional magnetic resonance imaging (fMRI) data. Specifically, the paper focuses on the following points: 1. **Limitations of existing research**: - Although many studies have shown that GNNs can improve disease - classification performance and highlight potential biomarker features, the significant features in these studies vary greatly among multiple studies on the same disease. - There is insufficient robustness assessment of these potential biomarkers and a lack of objective evaluation criteria. 2. **Research objectives**: - Provide a comprehensive review of how to apply GNNs and model - interpretation techniques to fMRI datasets for disease - prediction tasks, with particular attention to the generation of robust biomarkers for neurodegenerative diseases (such as dementia, Parkinson's disease) and neuropsychiatric disorders (such as attention - deficit/hyperactivity disorder, autism - spectrum disorder, major depressive disorder, and schizophrenia). - Emphasize the problems in current research and propose new criteria and frameworks to assess the robustness of potential biomarkers. 3. **Research methods**: - Search for relevant literature through the PubMed and Scopus databases and screen out studies that apply GNNs to fMRI datasets. - Summarize and analyze the model designs, interpretation techniques, and potential biomarkers discovered in these studies. - Propose a new prediction - attribution - evaluation framework to provide guidance for future research. 4. **Main contributions**: - Outline the latest progress of GNNs in fMRI data analysis, especially in the application of model interpretation and potential biomarker discovery. - Point out the deficiencies in existing research, especially regarding the assessment of biomarker robustness. - Suggest establishing new criteria and methods to improve the reliability and repeatability of potential biomarkers. Through these efforts, the paper hopes to provide a more solid foundation for future neuroscience research and promote the discovery and clinical application of more robust biomarkers.